Literature DB >> 28101743

Imaging of cardiac sympathetic activity in heart failure: Not out of the woods yet.

Catherine Gebhard1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28101743     DOI: 10.1007/s12350-017-0779-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  30 in total

1.  Key issues in end point selection for heart failure trials: composite end points.

Authors:  James D Neaton; Gerry Gray; Bram D Zuckerman; Marvin A Konstam
Journal:  J Card Fail       Date:  2005-10       Impact factor: 5.712

2.  Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol.

Authors:  Raffael Fraga; Fábio G Franco; Fabiana Roveda; Luciana N J de Matos; Ana M F W Braga; Maria U P B Rondon; Daniel R Rotta; Patricia C Brum; Antonio C P Barretto; Holly R Middlekauff; Carlos E Negrão
Journal:  Eur J Heart Fail       Date:  2007-05-01       Impact factor: 15.534

3.  Exercise training in patients with severe congestive heart failure: enhancing peak aerobic capacity while minimizing the increase in ventricular wall stress.

Authors:  L Demopoulos; R Bijou; I Fergus; M Jones; J Strom; T H LeJemtel
Journal:  J Am Coll Cardiol       Date:  1997-03-01       Impact factor: 24.094

4.  Controlled study of myocardial recovery after interval training in heart failure: SMARTEX-HF--rationale and design.

Authors:  Asbjørn Støylen; Viviane Conraads; Martin Halle; Axel Linke; Eva Prescott; Øyvind Ellingsen
Journal:  Eur J Prev Cardiol       Date:  2011-03-21       Impact factor: 7.804

5.  Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure.

Authors:  G A Somsen; B van Vlies; P A de Milliano; J J Borm; E A van Royen; E Endert; K I Lie
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

6.  Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.

Authors:  Christopher M O'Connor; David J Whellan; Kerry L Lee; Steven J Keteyian; Lawton S Cooper; Stephen J Ellis; Eric S Leifer; William E Kraus; Dalane W Kitzman; James A Blumenthal; David S Rendall; Nancy Houston Miller; Jerome L Fleg; Kevin A Schulman; Robert S McKelvie; Faiez Zannad; Ileana L Piña
Journal:  JAMA       Date:  2009-04-08       Impact factor: 56.272

7.  Increased norepinephrine spillover into the jugular veins in essential hypertension.

Authors:  C Ferrier; M D Esler; G Eisenhofer; B G Wallin; M Horne; H S Cox; G Lambert; G L Jennings
Journal:  Hypertension       Date:  1992-01       Impact factor: 10.190

8.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Authors:  M Packer; M R Bristow; J N Cohn; W S Colucci; M B Fowler; E M Gilbert; N H Shusterman
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245

9.  Exercise training normalizes sympathetic outflow by central antioxidant mechanisms in rabbits with pacing-induced chronic heart failure.

Authors:  Lie Gao; Wei Wang; Dongmei Liu; Irving H Zucker
Journal:  Circulation       Date:  2007-06-04       Impact factor: 29.690

10.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.